Extensive Small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-05-09
Clinical Trial Update: A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer [Phase 2]
Phase II clinical trial update for Cadonilimab in treatment-naïve or relapsed extensive small cell lung cancer.
CLINICAL_TRIALS trial_result · 2020-01-22
Clinical Trial Update: A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) [Phase 3]
Phase 3 trial evaluating TQB2450 or placebo with Anlotinib, Etoposide, and Carboplatin versus Etoposide and Carboplatin in extensive small c…